TLDR
- Verizon tops Dow dividend yields at 6.8% but dividend growth has lagged inflation at just 2% annually over the past decade
- Chevron delivers 4.6% yield with 37-year streak of increases, backed by integrated operations and 0.22 debt-to-equity ratio
- Merck offers 3.4% yield trading 25% below 2024 highs as company navigates upcoming patent expirations on key drugs
- Johnson & Johnson provides 3.0% yield with 62 consecutive years of increases and analyst price targets up to $227
- Coca-Cola and Realty Income round out list with 2.9% and 5.0% yields respectively
Dividend investors searching for income have six options in the Dow Jones Industrial Average with yields ranging from 2.9% to 6.8%. These companies span telecom, energy, healthcare, consumer goods, and real estate sectors. Each stock brings different risk profiles and growth potential.
Financial advisors caution that high yields alone do not make good investments. Investors must examine the underlying business strength and dividend sustainability. The companies must also fit within an investor’s overall portfolio strategy and risk tolerance.
Verizon Communications
Verizon leads the Dow with a 6.8% dividend yield. The telecom company benefits from stable customer retention patterns as subscribers typically stay with providers for years. Its networks require constant capital spending to stay competitive with rivals.
Verizon Communications Inc., VZ
The company carries material debt levels typical for the telecom industry. Dividend growth has averaged only 2% per year over the past decade. This trails inflation and reduces the dividend’s purchasing power over time.
Verizon recently hired a new CEO to boost growth prospects. The leadership change brings both opportunities and risks for shareholders. The stock trades at $41 with analysts setting an average price target of $48.50.
Twelve analysts rate it a “Buy” while some maintain cautious outlooks. Scotiabank points to subscriber additions as a positive factor.
Chevron Corporation
Chevron offers a 4.6% yield supported by 37 years of consecutive dividend increases. The energy company operates across production, pipelines, and refining. This diversification helps stabilize earnings through commodity price cycles.
The company maintains a strong balance sheet with a 0.22 debt-to-equity ratio. Management can borrow during downturns to fund operations and dividends. When oil prices recover, Chevron reduces leverage for the next cycle.
The stock trades near $152 with 17 analysts rating it a “Buy”. Price targets average $172 across Wall Street firms. HSBC set a $169 target highlighting share buyback programs while Wells Fargo maintains a $196 target.
Merck & Company
Merck provides a 3.4% yield while trading about 25% below 2024 highs. The pharmaceutical giant faces patent expirations on major drugs in coming years. These patent cliffs typically pressure revenues until new products fill the gap.
The company’s dividend payout ratio sits at 45%, leaving room to maintain payments. Keytruda generates over $25 billion in annual sales for Merck. Drug companies usually replace lost revenue through new drug development or acquisitions.
The stock trades around $100 after climbing 41% over six months. Thirteen analysts rate it a “Buy” with a $107 average target. J.P. Morgan and Goldman Sachs both raised targets to $120 based on pipeline developments.
Johnson & Johnson
Johnson & Johnson yields 3.0% with 62 straight years of dividend increases. The healthcare company trades at $206, up 14% year-to-date. Its oncology products drive current growth while the medical device division adds stability.
Fifteen analysts rate the stock a “Buy” with an average price target of $198. Guggenheim analyst Vamil Divan recently raised his target to $227. Barclays maintains an “Equal-Weight” rating at $197 with projected earnings of $10.86 per share in 2025.
Coca-Cola Company
Coca-Cola delivers a 2.9% yield backed by 63 years of dividend growth. The beverage company trades near $73 with gains from emerging markets. The global footprint provides revenue diversification across regions.
Thirteen analysts give it a “Strong Buy” rating with an $82 price target from UBS. The firm discussed the company’s AI strategy implementation. Bank of America set an $80 target pointing to a 25% increase in net income.
Realty Income Corporation
Realty Income yields 5.0% with monthly dividend payments. The real estate investment trust owns 15,500 properties under long-term leases. The portfolio focuses on retail properties designed to withstand e-commerce pressure.
The stock trades around $59 with analysts setting a $62 average target. Barclays notes $6 billion in planned 2025 investments supporting the dividend. Thirteen analysts give it a “Hold” rating reflecting current valuation levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
